Skip to content

Effectiveness of A Multi-Component Self-Management Intervention for Anxiety and Respiratory-Related Symptoms in Patients With Lung Cancer

Effectiveness of A Multi-Component Self-Management Intervention for Anxiety and Respiratory-Related Symptoms in Patients With Lung Cancer: A 3-Arm Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07782710
Enrollment
189
Registered
2026-08-24
Start date
2027-01-01
Completion date
2030-01-01
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Lung cancer patients, Anxiety, Respiratory-related symptoms, Mindfulness-based cognitive therapy, Respiratory distress symptom intervention

Brief summary

The study aims to examine the effectiveness of M-RDSI (Mindfulness-Respiratory Distress Symptom Intervention) in Hong Kong (HK) Chinese patients with lung cancer (LC). Investigators will conduct a three-arm mixed-methods randomized controlled trial (RCT) involving 189 patients with LC.The three groups are M-RDSI, RDSI (Respiratory Distress Symptom Intervention), and usual care. The M-RDSI group includes standard RDSI training sessions, along with four additional 30-minute sessions dedicated to practicing core exercises from MBCT. These sessions are facilitated by a trained nurse and will be held at the hospital or PolyU, depending on the participants' preferences. The RDSI group will receive four evidence-based components at the hospital or PolyU, depending on the participants' preferences. The usual care group will receive health educational booklets based on the original RDSI materials, which have been adapted for HK LC patients.The study will be conducted at Chinese University of HK, Prince of Wales Hospital. Data collection will be conducted at baseline, week 6, and week 12 after the completion of the intervention. Multiple assessment timepoints will capture changes over time.

Interventions

BEHAVIORALM-RDSI

The M-RDSI group includes standard RDSI training sessions, along with four additional 30-minute sessions dedicated to practicing core exercises from MBCT. These sessions are facilitated by a trained nurse and will be held at the hospital or PolyU, depending on the participants' preferences. For the mindfulness component, four techniques will be taught, which include 'mindful breathing', 'automatic pilot' exercise, 'thoughts are not the facts' exercise, and 'body scan meditation'. The M-RDSI group will also be advised to practice the mindfulness skills when feeling anxious. Participants will be requested to complete an intervention adherence diary and provided with access to the relevant online materials already adapted for HK patients with LC.

BEHAVIORALRDSI

The RDSI group contains four evidence-based components: (1) controlled diaphragmatic breathing exercises and calming techniques, (2) cough easing techniques which educate patients to identify warning signs of cough and to apply modified swallow techniques or relaxed throat breathing, (3) acupressure with self-applied pressure for 1 minute on acupressure points: L7, L9 and L14 (hand/wrist areas), CV21 and 22 (sternum) and ST36 (knee)), and (4) tips for increasing activity levels. Participants will be requested to complete an intervention adherence diary and provided with access to the relevant online materials already adapted for HK patients with LC.

BEHAVIORALUsual Care

The Usual care group will receive health educational booklets including brief tips for symptom management based on original RDSI materials and adapted with HK LC patients.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER
Research Grants Council, Hong Kong
CollaboratorOTHER
Prince of Wales Hospital, Shatin, Hong Kong
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\) HK residents who understand Cantonese, 18 years or older; * 2\) diagnosed intrathoracic malignancy (small/non-small cell LC, secondary LC, mesothelioma); receiving cancer treatment or palliative care; * 3\) self-report presence of at least two of the three respiratory-related symptoms (breathlessness/cough/fatigue), AND one symptom is breathlessness. Patients screened as per original RDSI and HK pilot study, by asking (i) do you have breathlessness/cough/fatigue, if 'yes', (ii) is your daily life impacted by breathlessness/cough/fatigue? * 4\) at least moderate level of anxiety (STAI-State score ≥ 38) (primary outcome); * 5\) WHO Performance Status of 0-2.

Exclusion criteria

* 1\) acute exacerbation of COPD/chest infection within past 4 weeks that necessitated a change in medication, * 2\) received radiotherapy to the chest in previous 4 weeks, or surgical treatment for LC in previous 6 weeks.

Design outcomes

Primary

MeasureTime frameDescription
anxietyBaseline, Week 6, and Week 12Chinese version of the state-anxiety form of the State-Trait Anxiety Inventory (STAI-Y) with 20 items, total scores range from 20 to 80; higher scores represent higher state-anxiety levels. Scores are classified: 20-37 as mild, 38-44 as moderate and 45-80 as high. The Chinese version of the STAI is validated in the Chinese population.

Secondary

MeasureTime frameDescription
breathlessnessBaseline, Week 6, and Week 12All participants will use Dyspnoea-12 to collect data on breathlessness.
coughbaseline, week 6, and week 12All participants will use the Leicester Cough Questionnaire to collect data on cough.
fatiguebaseline, week 6, and week 12All participants will use the Functional Assessment of Chronic Illness Therapy-Fatigue to collect data on fatigue.
mindfulnessbaseline, week 6, and week 12All participants will use the Mindful Attention Awareness Scale to collect data on mindfulness.
HRQoLbaseline, week 6, and week 12All participants will use the EuroQoL 5-Dimension 5-Level to collect data on HRQoL.

Contacts

CONTACTKa Yan Ho
kyeva.ho@polyu.edu.hk+8527666417

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026